Purchase Order 75D30120P08786
Award Date 7/23/20
Potential Completion Date 8/30/20
Potential Value $247K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
- The Centers for Disease Control and Prevention (CDC) awarded a $200,000.00 firm fixed price purchase order to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc., a biotechnology company specializing in protein microarray technology. The contract is for the identification of Brucella canis and B. abortus RB51 seroreactive proteins and the development of serology assays. This sole-source contract was awarded without a set-aside designation. Antigen Discovery has extensive...
- This SBIR Phase I contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $150,000.00 firm fixed price purchase order is for the company's high throughput protein microarray technology and related services. Immport Therapeutics has provided these products and services to support the CDC's detection and response efforts for pathogens such as monkeypox virus, Brucella,...
- The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract worth $87,600 to Federon Procurement Solutions, a minority-owned, self-certified small disadvantaged business in Alexandria, Virginia. The contract is for the bulk production of oligonucleotides and synthetic genes to support the development of Candidate Vaccine Viruses (CVVs) at the CDC Influenza Division. This requirement was originally posted as an $87,600 Request for Quotations (RFQ)...
- This $120,750 Firm Fixed Price purchase order was awarded to Sino Biological US Inc. by the Centers for Disease Control and Prevention (CDC) on September 28, 2024. The contract is for PROTEIN PRODUCTION FOR CVV (Candidate Vaccine Virus) and is set aside for Total Small Business. Sino Biological US Inc. is a foreign-owned, self-certified small disadvantaged business that manufactures biological goods. The company has a proven track record of providing proteins and other materials to support...
- The Centers for Disease Control and Prevention (CDC) awarded Sino Biological US Inc., a foreign-owned small disadvantaged business and manufacturer of goods, a $249,050 firm fixed-price purchase order for protein production to support viral disease prevention and control efforts. The award has no set-aside designation. In addition to this prime federal contract, Sino Biological has received awards from other agencies such as the National Institutes of Health (NIH) for generating materials to aid...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $238,706 firm-fixed-price purchase order contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for an effective surface sampling and processing tool to detect microbial contamination. Ai Biosciences, a biotechnology research company, has previously received multiple SBIR awards from NASA, NIH, and CDC to develop advanced diagnostic technologies,...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to the National Institute For Scientific And Industrial Research, a non-profit organization, on September 18, 2017. The contract, which does not have a set-aside designation, is for critical functions with a potential value of $147,000.00. The period of performance for this contract is through January 17, 2019, and the place of performance is in Atlanta,...
- The Centers for Disease Control and Prevention awarded Abcellera Biologics Inc. a definitive fixed price contract valued at $884,000 to provide a transgenic mouse model capable of generating humanized antibodies against influenza viruses. The original solicitation sought proposals for a mouse engineered with human immunoglobulin gene segments to better recapitulate the human antibody repertoire when testing candidate virus strains and developing antibodies. Under the contract, Abcellera will...